Loading…
← CockpitCompetitor Analysis › AGL agilon health incOpen in the cockpit ↗

agilon health incAGLCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical/Nursing Services

Partners with independent primary care physician groups to manage Medicare Advantage patients under value-based, full-risk contracts.

Momentum strong 65
Mkt cap
$1.52B
US dollars, full cap
Free float
70%
of shares outstanding
$/day
$25.1M
20-day average traded
Fwd P/E
34.1×
forward earnings
ROIC−WACC
n/a
WACC 19.8%
Hurdle
n/a
no reverse DCF
Next earnings
105 days
3 Mar 2027
Close · USD$90.53
1D-21.4%
1W-21.1%
1M-1.3%
3M-2.4%
6M+11.8%
YTD+425.8%
1Y+574.3%
ATR %9.3%
Beta1.57
52w lowhigh31.9% off high

What agilon health does

Partners with independent primary care physician groups to manage Medicare Advantage patients under value-based, full-risk contracts.

Receives a fixed share of each Medicare Advantage member's premium from the health plan and pays the medical bills, so it profits when members' care costs less than the premium and loses when costs run higher; the physician groups share in the result. It has pulled back from some unprofitable markets.

Products and services

  • Value-based care platform for primary care groups
  • Medicare Advantage risk-contract management
  • Care coordination/analytics tools

Customers

  • Independent primary care physician groups
  • Medicare Advantage patients

Where it sits in the supply chain

  • Health care services
  • Value-based primary care platform
  • Medicare Advantage risk-sharing…

What could go right

  • Medicare Advantage value-based care shift
  • Geographic market/physician-group expansion

What could go wrong

  • Medical cost trend/utilization risk under full-risk contracts
  • Medicare Advantage reimbursement policy risk

Moat: narrow (switching costs, data, process know-how). Long-term partnerships with physician groups embed agilon's risk-management platform and analytics into daily care.

Headquarters: Long Beach, California · Founded: 2016 · Employees: 856

Named competitors

agilon health at a glance

Size agilon health (AGL) is a United States Health Care company (Medical/Nursing Services) with a market value of $1.52B, the 1966th largest of 3,085 United States companies the cockpit tracks. Shares closed at $90.53 on 18 Nov 2026.

Performance Over six months the shares gained 11.8%, against +17.1% for the median peer and -2.2% for the United States market (cap-weighted) — 10th lowest of 21 in its peer set.

Growth Revenue grew 2.0% over the last twelve months (peer median +9.2%); the operating margin is -1.7% (peer median 6.2%).

Valuation It trades at 34.1× forward earnings against a peer median of 29.4× (6th most expensive of 16).

Short interest Short interest is 5.0% of the free float (30 Oct 2026).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012014016021 May 202621 Aug 202618 Nov 2026Peer median 115AGL 112
Six months, rebased to 100: agilon health against the median of its 20 peers (local-currency closes).

agilon health financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$6.00B$5.93B$6.06B$4.32B$2.39B
Revenue growth—-2%+40%+81%—
Gross profit$152M-$189M-$19.6M$53.6M$102M
EBITDA-$72.2M-$392M-$259M-$212M-$89.1M
Net income-$106M-$405M-$251M-$215M-$107M
Free cash flow-$18.6M-$119M-$71.0M-$172M-$146M
Capital expenditure$20.4M$43.1M$41.3M$30.8M$32.7M
Total debt$33.4M$36.8M$44.0M$52.3M$56.0M

Quarterly statements and history in the cockpit →

agilon health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%0%+20%WGSTDOCAMBEASNDA4544USPHPSNLVIJAYA1833300244LMRICLARIEMEISDIAPNTGOPKMETROPOLISAGARWALEYENUTXAGL6-month return →1-month return →
Up and to the right = strong over both horizons. agilon health is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%25×50×75×WGSAMBEA4544USPHVIJAYA1833300244LMRICLARIDIAPNTGMETROPOLIS603882AGARWALEYENUTXAGLRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. agilon health is the large dot.

agilon health competitors and peer comparison

Head to head with its named competitors (AGL vs CVS vs PRVA vs CLOV)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
agilon health AGL$1.52B+12%+2%-2%34.1×n/a
CVS Health CVS$104B-13%+7%4%9.6×-3.8%
Privia Health PRVA$3.14B+6%+19%2%55.1×n/a
Clover Health Investments CLOV$2.21B+16%+54%0%52.0×n/a

How agilon health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

agilon health against its 20 peers (data as of 18 Nov 2026)
MeasureAGLPeer medianRank in peer set
1-month return-1.3%+1.3%10th lowest of 21
6-month return+11.8%+17.1%10th lowest of 21
Distance from 52-week high-31.9%-22.2%6th lowest of 21
Revenue growth (TTM)+2.0%+9.2%8th lowest of 21
Operating margin-1.7%6.2%6th lowest of 21
Forward P/E34.1×29.4×6th most expensive of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
agilon health AGLUnited States$1.52B+12%+2%-2%34.1×n/an/a
GeneDx WGSUnited States$1.56B+16%+15%-14%54.2×n/an/a
Teladoc Health TDOCUnited States$1.47B+24%-2%-5%n/a-6.4%+18.3%
Ambea AMBEA.STSweden$1.59B+28%+11%9%15.2×1.1%+7.7%
Sonida Senior Living SNDAUnited States$1.59B-11%+70%-8%n/an/an/a
H.U.Group 4544.TJapan$1.44B+24%+1%3%39.9×9.7%+2.1%
U.S. Physical Therapy USPHUnited States$1.42B+53%+10%10%29.4×18.8%+13.0%
Personalis PSNLUnited States$1.62B+88%+17%-157%n/an/an/a
Vijaya Diagnostic Centre VIJAYA.NSIndia$1.69B+18%+24%32%63.0×40.4%+16.7%
Ping An Healthcare and Technology 1833.HKHong Kong$1.36B-47%+8%3%33.5×3.5%-5.1%
Dian Diagnostics 300244.SZChina$1.70B+1%-5%9%21.8×0.3%-1.1%
Lumexa Imaging LMRIUnited States$1.35B+89%+8%2%16.0×n/an/a
Clariane CLARI.PAFrance$1.32B-20%+1%6%8.2×6.8%+6.5%
Emeis EMEIS.PAFrance$1.78B-33%+4%3%n/a21.2%+8.5%
Diagnostyka DIA.WAPoland$1.28B-6%+19%15%19.5×7.3%+18.9%
Pennant PNTGUnited States$1.26B+1%+39%6%23.7×20.7%+19.4%
OPKO Health OPKUnited States$1.25B+37%-22%-29%n/an/an/a
Metropolis Healthcare METROPOLIS.NSIndia$1.25B+11%+20%18%44.5×32.4%+10.5%
Guangzhou Kingmed Diagnostics 603882.SSChina$1.86B+5%-3%7%29.9×5.4%-6.1%
Dr. Agarwal's Health Care AGARWALEYE.NSIndia$1.86B+20%+26%15%77.1×43.0%+26.9%
Nutex Health NUTXUnited States$1.19B+42%-19%39%6.5×-18.0%+253.5%

Questions

Who are agilon health's main competitors?
Named competitors: CVS Health (Oak Street Health) (CVS), Privia Health Group (PRVA), Clover Health (CLOV). The cockpit's measured peer set (industry) also includes GeneDx (WGS), Teladoc Health (TDOC), Ambea (AMBEA.ST), Sonida Senior Living (SNDA), H.U.Group (4544.T), U.S. Physical Therapy (USPH).
Is agilon health expensive compared with its peers?
On forward p/e it trades at 34.1× against a peer median of 29.4×, 6th most expensive of 16 in its peer set.
How has agilon health stock performed?
Over six months to 18 Nov 2026 the shares returned +11.8% against +17.1% for the median peer; over one year +574.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.